{"id":"W2044991833","doi":"10.1177/0091270007307572","title":"Pharmacokinetics of Lamivudine, Zidovudine, and Nevirapine Administered as a Fixed‐Dose Combination Formulation Versus Coadministration of the Individual Products","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nuvo Pharmaceuticals (Canada); Patheon (Canada); BioPhage Pharma (Canada); Quebec Rehabilitation Research Network","funders":"","keywords":"Nevirapine; Fixed-dose combination; Lamivudine; Zidovudine; Pharmacokinetics; Bioequivalence; Pharmacology; Medicine; Crossover study; Viral load; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003091674,0.0001330033,0.0004838693,0.0001117257,0.00006063714,0.000004459596,0.0001657574,0.0001007396,0.00006964818],"category_scores_gemma":[0.0007344729,0.00007545854,0.0001225678,0.000266619,0.0002559939,0.0001010875,0.00006626223,0.0003631822,0.000001944613],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002783948,"about_ca_system_score_gemma":0.0003479149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001806873,"about_ca_topic_score_gemma":0.000003557629,"domain_scores_codex":[0.9975698,0.0002325274,0.0015055,0.0001074994,0.0004302407,0.0001544602],"domain_scores_gemma":[0.9964486,0.001307314,0.001486682,0.000128204,0.0005253055,0.0001039201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1388716,0.01736918,0.3050473,0.001298793,0.0108456,0.0002672132,0.008166286,0.0001620534,0.302056,0.003332427,0.06767248,0.1449111],"study_design_scores_gemma":[0.05174845,0.008568069,0.6201425,0.0001763935,0.004943497,0.0003184908,0.0004037982,0.0003710804,0.3008617,0.0004411003,0.01183119,0.0001936376],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870693,0.0002900139,0.00006101698,0.01020298,0.001315906,0.0005368809,0.000004984189,0.000004908002,0.0005139963],"genre_scores_gemma":[0.9977846,0.0005321685,0.0004903661,0.0003659115,0.000411211,0.000001664757,0.00001008878,0.00001047949,0.0003935154],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3150952,"threshold_uncertainty_score":0.307711,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1195877454496215,"score_gpt":0.4448748509857567,"score_spread":0.3252871055361352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}